Adenosine (CED0000456)

Record Information
Version1.0
Creation Date2014-08-29 06:11:54 UTC
Update Date2026-05-14 16:44:49 UTC
SynCED IDCED0000456
Secondary Accession Numbers
  • CHEM003235
  • T3D4275
Identification
Common NameAdenosine
ClassSmall Molecule
Description
Adenosine belongs to the purine nucleosides, a class of nucleosides, nucleotides, and analogues within the organic compounds. It has the chemical formula $\text{C}_{10}\text{H}_{13}\text{N}_5\text{O}_4$ and an average molecular weight of 267.24 g/mol. This endogenous compound exists as a solid at room temperature and is detected in all tissues. It functions biologically as a human metabolite, a ligand (PMC13414883 ), an agonist (PMC2888900 ), and an antioxidant (PMC11121823 ). Its protein targets include the adenosine receptors A1, A2a, A2b, and A3, among six other proteins. Adenosine is utilized as an anti-arrhythmia drug, a vasodilator agent, and an analgesic. Industrially, it is used as a softener and conditioner. It is recorded as being found in indoor air, cardiac preparations, bleaching agents, cigar cigarettes, and food processing and cookware, including the preparation of wort, vinegar, wine or sparkling wine, and fermentation processes for beer. It is also found in television systems and video games. Recorded exposure routes include oral, intravenous, topical, dental, vaginal, and inhalation. In terms of health effects, adenosine is a treatment for heart disease (PMC9962797 ). It has therapeutic effects on blood pressure (PMC11121823 ), ischemia (PMC2888900 ), and inflammation (PMC12599235 ). Conversely, it is associated with neuroblastoma (PMC8962291 ) and an increase in inflammation (PMC7246765 ).
Contaminant Type
  • Amine
  • Analgesic
  • Animal Toxin
  • Anti-Arrhythmia Agent
  • Cardiovascular Agent
  • Drug
  • Ether
  • Food Toxin
  • Human Neurotoxin
  • Metabolite
  • Natural Compound
  • Organic Compound
  • Vasodilator Agent
Chemical Structure
Synonyms
ValueSource
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diolChEBI
6-Amino-9-beta-D-ribofuranosyl-9H-purineChEBI
9-beta-D-RibofuranosidoadenineChEBI
9-beta-D-Ribofuranosyl-9H-purin-6-amineChEBI
Ade-ribChEBI
Adenine deoxyribonucleosideChEBI
AdenocardChEBI
AdenocorChEBI
AdenoscanChEBI
AdenosinChEBI
AdenyldeoxyribosideChEBI
AdoChEBI
beta-D-AdenosineChEBI
DeoxyadenosineChEBI
DesoxyadenosineChEBI
6-Amino-9-b-D-ribofuranosyl-9H-purineGenerator
6-Amino-9-β-D-ribofuranosyl-9H-purineGenerator
9-b-D-RibofuranosidoadenineGenerator
9-Β-D-ribofuranosidoadenineGenerator
9-b-D-Ribofuranosyl-9H-purin-6-amineGenerator
9-Β-D-ribofuranosyl-9H-purin-6-amineGenerator
b-D-AdenosineGenerator
Β-D-adenosineGenerator
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-ribofuranoseHMDB
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-ribofuranoseHMDB
6-Amino-9beta-D-ribofuranosyl-9H-purineHMDB
6-Amino-9beta-delta-ribofuranosyl-9H-purineHMDB
9-beta-D-ArabinofuranosyladenineHMDB
9-beta-D-RibofuranosyladenineHMDB
9-beta-delta-ArabinofuranosyladenineHMDB
9-beta-delta-RibofuranosidoadenineHMDB
9-beta-delta-Ribofuranosyl-9H-purin-6-amineHMDB
9-beta-delta-RibofuranosyladenineHMDB
9beta-D-Ribofuranosyl-9H-purin-6-amineHMDB
9beta-D-RibofuranosyladenineHMDB
9beta-delta-Ribofuranosyl-9H-purin-6-amineHMDB
9beta-delta-RibofuranosyladenineHMDB
Adenine nucleosideHMDB
Adenine ribosideHMDB
Adenine-9beta-D-ribofuranosideHMDB
Adenine-9beta-delta-ribofuranosideHMDB
beta-AdenosineHMDB
beta-delta-AdenosineHMDB
BonitonHMDB
MyocolHMDB
NucleocardylHMDB
SandesinHMDB
Chemical FormulaC10H13N5O4
Average Molecular Mass267.241 g/mol
Monoisotopic Mass267.097 g/mol
CAS Registry Number58-61-7
IUPAC Name(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
Traditional Nameadenosine
SMILESNC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
InChI IdentifierInChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
InChI KeyOIRDTQYFTABQOQ-KQYNXXCUSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety.
KingdomOrganic compounds
Super ClassNucleosides, nucleotides, and analogues
ClassPurine nucleosides
Sub ClassNot Available
Direct ParentPurine nucleosides
Alternative Parents
Substituents
  • Purine nucleoside
  • Glycosyl compound
  • N-glycosyl compound
  • 6-aminopurine
  • Pentose monosaccharide
  • Imidazopyrimidine
  • Purine
  • Aminopyrimidine
  • Monosaccharide
  • N-substituted imidazole
  • Pyrimidine
  • Imidolactam
  • Tetrahydrofuran
  • Azole
  • Imidazole
  • Heteroaromatic compound
  • Secondary alcohol
  • Organoheterocyclic compound
  • Azacycle
  • Oxacycle
  • Organic oxygen compound
  • Organic nitrogen compound
  • Alcohol
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Organopnictogen compound
  • Organooxygen compound
  • Amine
  • Primary alcohol
  • Primary amine
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginEndogenous
Cellular Locations
  • Extracellular
  • Lysosome
  • Membrane
  • Mitochondria
Biofluid LocationsNot Available
Tissue Locations
  • All Tissues
Applications
Biological Roles
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting Point235.5°C
Boiling PointNot Available
Solubility8230 mg/L
Predicted Properties
PropertyValueSource
Water Solubility14 g/LALOGPS
logP-1.2ALOGPS
logP-2.1ChemAxon
logS-1.3ALOGPS
pKa (Strongest Acidic)12.45ChemAxon
pKa (Strongest Basic)3.92ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area139.54 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity63.2 m³·mol⁻¹ChemAxon
Polarizability25.28 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
GC-MSGC-MS Spectrumsplash10-0f7w-1890000000-5c70a5423faa5e8eceafNot AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-001v-0691000000-8f88854b7d5adec5c558Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-001s-0790000000-cc3bcd977e11efd4ea25Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-00di-9460000000-3ae19bfaa5d2df72f9b1Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0gc0-0590000000-05874cecded3009c1f4dNot AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0fsv-1792000000-b37fd6826f28aaf9e825Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0f7w-1890000000-5c70a5423faa5e8eceafNot AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-001v-0691000000-8f88854b7d5adec5c558Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-001s-0790000000-cc3bcd977e11efd4ea25Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-00di-9460000000-3ae19bfaa5d2df72f9b1Not AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0gc0-0590000000-05874cecded3009c1f4dNot AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0fsv-1792000000-b37fd6826f28aaf9e825Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0a4v-9560000000-986f3b1dfa5d898ed7a2Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-01c4-6912500000-ae103f43432726c1ad22Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014r-0890000000-588861a9494ab4680698Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-1900000000-dd7cbed8e76c6e783831Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-2900000000-c6644520b5943b59403dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0090000000-3d4fd8ea211eaed10531Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-cb58ec56a5faa09c9a02Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-9559aa07ec13a688fb16Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-f7c1371d8e1058df3a32Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0940000000-da71247788bf1ba222e2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0920000000-f2e8ec028abdd674b5e3Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0910000000-815ed65588c07415cd65Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-1910000000-2780e737da8848411c4fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-053r-1900000000-c6c1128990661334c15bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0090000000-106e7131507fadd4befbNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0910000000-1c53823486cd2c23f90eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-f0313435db4847490fd6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-1900000000-dcd4c2972882dcd7535aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-2900000000-5ee474864189cef6df64Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-17edf36faf6eb5750912Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-0591143763a0bad31c23Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0290000000-f1d71a97ce39145c8e31Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kr-0950000000-9bbdbb14aed287ad5ac8Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0910000000-35f90965f1f3c2b3236bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-f360cca994696d7ae735Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0910000000-65268017a112bc263b5eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-375c0e137f7068cf49afNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-ad5db8e5cbaacc341347Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-718be441310a581854a6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-765c0fccf80d24951ef9Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-053r-2900000000-2f0ca594f7cc031e54e7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0940000000-da71247788bf1ba222e2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0920000000-f2e8ec028abdd674b5e3Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0910000000-815ed65588c07415cd65Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-1910000000-bbdd67de0fcb7c302c8fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-053r-1900000000-2c12434eaabba59a0a6cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0910000000-35f90965f1f3c2b3236bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0980000000-56af5755b924f7c42369Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0980000000-25acc7da5b6ea2bee529Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-3900000000-602d3adcf68051f2992dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-4900000000-85777953862ffa85a828Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0090000000-8c7c25ea99344e167af5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0090000000-2de6609bcaad91b510b5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kr-0940000000-a6eb3acc66bfb4687127Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-38a0b51e84259a90e0bfNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-95ff80024f6f3ecb8b96Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-54121dd1ddff8baeedbdNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-bc944eede02f73a9f09cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-1900000000-bf97b22e23b479deb25bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0490000000-47f7a73ecc9fc3610eacNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-e43eddf41f22caa830b7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-5ff3043042220443b986Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-7157f8ad056eb2a71278Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-a82c9cbf7a2ae7b92911Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kr-0960000000-c27288ef88b7c9fada7cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-b9c204c25a40d0b9d54eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-d29b79bb7074f6b6007fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0090000000-106e7131507fadd4befbNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0910000000-1c53823486cd2c23f90eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-f0313435db4847490fd6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-1900000000-23bcec0b5be3fa4e10edNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-2900000000-60219ac7d9220e297492Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-cda34117888d584ca7b7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0910000000-83e1685b54e8f76906fdNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0920000000-985897f3309c69d2acfbNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0930000000-9e6777212cb3a21a3a83Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0940000000-a9e90a868ea4f0f6fdb3Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-cb58ec56a5faa09c9a02Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-9559aa07ec13a688fb16Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-f7c1371d8e1058df3a32Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0290000000-f1d71a97ce39145c8e31Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kr-0950000000-9bbdbb14aed287ad5ac8Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-f360cca994696d7ae735Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-fef79893c00d065702b7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-ea11cf8ac5af935bddf7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-02t9-0294000000-abb236da520f6aef0219Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0092000000-d2d13a36535aa8fc719bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03fr-0039520000-ff390a49e70c3ce16d6dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-01t9-0039810000-72148f451c6faa94b6a0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-3900000000-d46a6ac68cff3d0c9020Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kr-2900000000-b48b98b8bd78124c973aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0910000000-d27a25cc7e3d4ca0ee30Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kr-0950000000-9bbdbb14aed287ad5ac8Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0190000000-972617aeea484bc69504Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-16c7eff441e7b3ef1decNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0910000000-556dd638b3946e92d18fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-1900000000-0f76e400a56cad0d0fcaNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0910000000-eb8f981c9f5761f4aef0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-3900000000-a96b5003a9deeb15fd60Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-91d7c687ea8980483203Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-cc7bce597b4e8b81114cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0920000000-ec87f5fb7f40c8031b5dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0930000000-5e1a2467e05e9881c30cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-f21d1fe32219b2d87c4aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-1f41894ddadd92a53983Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0920000000-ffd1d1333b422916c951Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-053r-2900000000-ae2b37fab44920fe5488Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0940000000-eedba16613a4f4606fa4Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0910000000-c5ab43a44bfd6f4bfa76Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0910000000-5c55218fff6dc57de94aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-6bf8c249ab7dedb5c5baNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-db0eb7e2765f6507daadNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-e3a7c00866297f9ae2f6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-ac59f9827d1403a36994Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kr-0940000000-4fdc75cfd8f86b40d63fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-ad5db8e5cbaacc341347Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-c6d3d25b55bb8954c51fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-8a559a8354e4a9c7c734Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-20ee7155dcc9a2f25dd8Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-4900000000-c3a85b3ebc475961ab27Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0490000000-47f7a73ecc9fc3610eacNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-e43eddf41f22caa830b7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-2900000000-ec91fb8b2bba2c94cc8eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0910000000-a4f024474d1b16b730a2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00lr-0940000000-60c91f26448258d0d725Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-1900000000-9bc4a25c0671e6ed6269Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-b594a436f16f82f2b20bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-7157f8ad056eb2a71278Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-5ff3043042220443b986Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-8138a76cc115bab4ea76Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-4c21bed39b4a0c332c3eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-1900000000-10f5c1e11f71f0ec6059Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-58a9f73d4a5431a1c4ebNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-1900000000-4f2277965db87828da90Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-e9ed0937d9e1e01d3d9bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-208d8f6ac88301b7a82eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-77bf6a2e15ca7d3680fcNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0900000000-89aa4631ac19b788a129Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0940000000-3a1cdf7153df4988110bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-1900000000-85200098720c40401635Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kr-0960000000-0667192f283585a81ab3Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-a82c9cbf7a2ae7b92911Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-3900000000-e45c9fecc602c23b739dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-0940000000-42bee9785f9b55b32eeaNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-0900000000-c8cda6a661ace060572cNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-2900000000-0304a85c3951aa1cb41aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0159-0690000000-0258e5851611884483d9Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-0900000000-e6b8fc6980387f646d64Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-053r-2900000000-1e0cad8d044715d90f12Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-0920000000-7da3fd2802cd6cdf6c8dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-0900000000-c1ee2199364d0258bae1Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-1900000000-f3490e8ccb46290343ecNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-0920000000-dd81be3fe27885082ecaNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-0900000000-fb75e80e5587bfdc5dc8Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a59-2900000000-d8479f55e1fca34f9c15Not AvailableView Spectrum
1D NMR1H NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
1D NMR13C NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
1D NMR13C NMR Spectrum (1D, H2O, experimental)Not AvailableNot AvailableView Spectrum
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
953.0 Log mg/kg [540:1700]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityAdenosine slows conduction time through the AV node and can interrupt the reentry pathways through the AV node, resulting in the restoration of normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT), including PSVT associated with Wolff-Parkinson-White Syndrome. This effect may be mediated through the drug's activation of cell-surface A1 and A2 adenosine receptors. Adenosine also inhibits the slow inward calcium current and activation of adenylate cyclase in smooth muscle cells, thereby causing relaxation of vascular smooth muscle. By increasing blood flow in normal coronary arteries with little or no increase in stenotic arteries (with little to no increase in stenotic arteries), adenosine produces a relative difference in thallous (thallium) chloride TI 201 uptake in myocardium supplied by normal verus stenotic coronary arteries.
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
hypertensionDecreased in Blood IndecreaseA disorder characterized by a pathological increase in blood pressure; a repeatedly elevation in the blood pressure exceeding 140 over 90 mm Hg. (NCI CTCAE)PMC11195684
blood pressureHas Therapeutic Effect OnNot AvailableNot AvailablePMC11121823
inflammationHas Therapeutic Effect OnNot AvailableNot AvailablePMC12599235
inflammationAssociated With?increaseNot AvailablePMC7246765 , PMC8161391
inflammationAssociated With?Not AvailableNot AvailablePMC12412055
cancerAssociated With?increaseCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. There are over 100 types of cancers affect humans. The risk of developing certain cancers can be reduced by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. The majority of cancers, some 90–95% of cases, are due to genetic mutations from environmental and lifestyle factors. The remaining 5–10% are due to inherited genetics.PMC8161391
cancerAssociated With?Not AvailableCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. There are over 100 types of cancers affect humans. The risk of developing certain cancers can be reduced by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. The majority of cancers, some 90–95% of cases, are due to genetic mutations from environmental and lifestyle factors. The remaining 5–10% are due to inherited genetics.PMC12412055
cancerElevated in Blood InincreaseCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. There are over 100 types of cancers affect humans. The risk of developing certain cancers can be reduced by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. The majority of cancers, some 90–95% of cases, are due to genetic mutations from environmental and lifestyle factors. The remaining 5–10% are due to inherited genetics.PMC6025448
asthmaAssociated With?Not AvailableA bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors. The disease has symptom recurring periods of wheezing (a whistling sound while breathing), has symptom chest tightness, has symptom shortness of breath, has symptom mucus production and has symptom coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, exercise, stress, reflux disease, medications, foods and emotional anxiety. (DO)PMC2733095
Hepatocellular carcinomaAssociated With?increaseA liver carcinoma that has material basis in undifferentiated hepatocytes. (DO)PMC13138852
heart failureHas Therapeutic Effect OnNot AvailableA disorder characterized by the inability of the heart to pump blood at an adequate volume to meet tissue metabolic requirements, or, the ability to do so only at an elevation in the filling pressure. (NCI CTCAE)PMC10918954
seizureNot AvailableNot AvailableNot AvailablePMC2728789
seizureHas Therapeutic Effect OnNot AvailableNot AvailablePMC2728789 , PMC12861575
heart diseaseNot AvailableNot AvailableA cardiovascular system disease that involves the heart. (DO)PMC9962797
ischemiaHas Therapeutic Effect OnNot AvailableA disorder characterized by a decrease or absence of blood supply to an organ or tissue, caused by obstruction (thrombosis or embolism) of an artery. (NCI CTCAE)PMC2888900
ischemiaAssociated With?Not AvailableA disorder characterized by a decrease or absence of blood supply to an organ or tissue, caused by obstruction (thrombosis or embolism) of an artery. (NCI CTCAE)PMC12412055
neuroblastomaAssociated With?Not AvailableAn autonomic nervous system neoplasm that derives from immature nerve cells. (DO)PMC8962291
coronary artery diseaseNot AvailableNot AvailableAn artery disease that is characterized by plaque building up along the inner walls of the arteries of the heart resulting in a narrowing of the arteries and a reduced blood supply to the cardiac muscles. (DO)PMC6529598
coronary artery diseaseAssociated With?Not AvailableAn artery disease that is characterized by plaque building up along the inner walls of the arteries of the heart resulting in a narrowing of the arteries and a reduced blood supply to the cardiac muscles. (DO)PMC6947158
Chronic Obstructive Pulmonary DiseaseAssociated With?Not AvailableA disorder characterized by long-term breathing problems and poor airflow, commonly attributed to smoking.PMC2733095
epilepsyNot AvailableNot AvailableA brain disease that is characterized by the occurrance of at least two unprovoked seizures resulting from a persistent epileptogenic abnormality of the brain that is able to spontaneously generate paroxysmal activity and typically manifested by sudden brief episodes of altered or diminished consciousness, involuntary movements, or convulsions. (DO)PMC8366481
epilepsyHas Therapeutic Effect OnNot AvailableA brain disease that is characterized by the occurrance of at least two unprovoked seizures resulting from a persistent epileptogenic abnormality of the brain that is able to spontaneously generate paroxysmal activity and typically manifested by sudden brief episodes of altered or diminished consciousness, involuntary movements, or convulsions. (DO)PMC2728789 , PMC12861575
Parkinson's diseaseAssociated With?decreaseA long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time.PMC10657172
arrhythmiaAssociated With?Not AvailableNot AvailablePMC12733572
arrhythmiaNot AvailableNot AvailableNot AvailablePMC13187934
brain cancerAssociated With?increaseNot AvailablePMC10441638
brain ischemiaAssociated With?increaseA disorder characterized by a decrease or absence of blood supply to the brain caused by obstruction (thrombosis or embolism) of an artery resulting in neurological damage. (NCI CTCAE)PMC7386554
migraineAssociated With?increaseA brain disease that is characterized by moderate to severe headaches, nausea, extreme sensitivity to light and sound and intense unilaterial throbbing or pulsing. (DO)PMC9881355
myocarditisAssociated With?increaseA disorder characterized by inflammation of the muscle tissue of the heart. (NCI CTCAE)PMC10918954
cardiovascular disorderAssociated With?Not AvailableNot AvailablePMC12412055
FibrosisHas Therapeutic Effect OnNot AvailableNot AvailablePMC10918954
FibrosisAssociated With?Not AvailableNot AvailablePMC10918954
bacterial infectious diseaseAssociated With?Not AvailableNot AvailablePMC12412055
brain neoplasmAssociated With?Not AvailableNot AvailablePMC10441638
autistic disorderIs Biomarker OfNot AvailableNot AvailablePMC12029135
lung non-small cell carcinomaAssociated With?increaseNot AvailablePMC13138852
hypotensive disorderAssociated With?Not AvailableNot AvailablePMC12733572
HypoxiaAssociated With?increaseNot AvailablePMC7246765 , PMC8161391
pain agnosiaHas Therapeutic Effect OnNot AvailableNot AvailablePMC12164251
cardiac rhythm diseaseNot AvailableNot AvailableNot AvailablePMC4353337
atrioventricular blockAssociated With?Not AvailableNot AvailablePMC12733572
BronchoconstrictionAssociated With?Not AvailableNot AvailablePMC2733095
Exposure Sources
Source IDSourceSectorReference
CEDs000019Indoor air?Indoor air can be a significant reservoir for synthetic chemical contaminants, which often originate from various sources within enclosed environments.Air, dust & atmospheric transportNot Available
CEDs000233Brushes?Brushes used in personal care and cosmetics can be a source of synthetic chemical contamination due to the materials and coatings used in their manufacturing.Personal care & cosmeticsPubChem
CEDs000288Cardiac preparations?Cardiac preparations are pharmaceuticals designed to treat various heart conditions, including heart failure and arrhythmias.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000511Conductors Or Conductive Bodies Characterised By The Conductive Materials?Conductors, or conductive bodies, are materials that allow the flow of electrical current, typically made from metals such as copper, aluminum, or silver.Electrical & Electronic EquipmentPubChem
CEDs000519Electrodes?Electrodes, used in various electrical and electronic applications, can be a source of synthetic chemical contamination due to the materials from which they are constructed and the processes involved in their manufacturing.Electrical & Electronic EquipmentPubChem
CEDs000537Television Systems?Television systems can be a source of synthetic chemical contamination due to the various materials and components used in their manufacture and operation.Electrical & Electronic EquipmentPubChem
CEDs000539Video Games?Video games, through their production and disposal processes, can be a source of synthetic chemical contamination.Electrical & Electronic EquipmentPubChem
CEDs000544Fermentation Processes For Beer?Fermentation processes for beer involve the conversion of sugars into alcohol and carbon dioxide by yeast.Food, food processing & cookwarePubChem
CEDs000545Food Preservation?Food preservation often involves the use of synthetic chemicals, such as preservatives, flavor enhancers, and color additives, to extend shelf life and enhance the sensory qualities of food products.Food, food processing & cookwarePubChem
CEDs000548Preparation Of Vinegar?Vinegar is produced through the fermentation of ethanol by acetic acid bacteria, resulting in a solution that typically contains 4-8% acetic acid.Food, food processing & cookwarePubChem
CEDs000549Preparation Of Wine Or Sparkling Wine?The preparation of wine or sparkling wine involves various stages, including fermentation, aging, and bottling, which can introduce potential sources of synthetic chemical contamination.Food, food processing & cookwarePubChem
CEDs000550Preparation Of Wort?The preparation of wort involves the extraction of sugars from malted grains, a crucial step in the brewing process.Food, food processing & cookwarePubChem
CEDs000555Bleaching Agents?Bleaching agents are chemical substances used to whiten or lighten materials, often employed in various cleaning products for their stain removal and disinfecting properties.Household cleaning & consumer productsPubChem
CEDs000556Cigar Cigarettes?Cigar cigarettes are a source of synthetic chemical contamination due to the combustion of various tobacco blends and additives.Household cleaning & consumer productsPubChem
CEDs000561Perfumes Within Detergents And Soaps?Perfumes within detergents and soaps are synthetic fragrance compounds added to enhance the sensory experience of cleaning products.Household cleaning & consumer productsPubChem
CEDs000563Soap Detergents?Soap detergents are synthetic surfactants designed to enhance the cleaning efficacy of water by reducing surface tension, allowing for better interaction with dirt and grease.Household cleaning & consumer productsPubChem
CEDs000569Tobacco Smoke Filters?Tobacco smoke filters are designed to reduce the inhalation of harmful substances in cigarette smoke, including tar and other particulate matter.Household cleaning & consumer productsPubChem
CEDs000580Manufacture Preparation Of Tobacco Products?The manufacture and preparation of tobacco products involve various processes that can result in the introduction of synthetic chemicals into the environment.Industrial manufacturing & chemical processingPubChem
CEDs000581Paper Making Machines?Paper making machines utilize various synthetic chemicals throughout the production process, including additives, coatings, and bleaching agents.Industrial manufacturing & chemical processingPubChem
CEDs000600Herbicides And Algicides?Herbicides and algicides are synthetic chemicals primarily used to control unwanted plants and algae in various environments.Agriculture & land managementPubChem
CEDs000606Plant Growth Regulators?Plant Growth Regulators (PGRs) are synthetic chemicals designed to influence the growth and development of plants.Agriculture & land managementPubChem
CEDs000610Aftersun Products?Aftersun products are designed to soothe and hydrate the skin after sun exposure, often containing various synthetic chemicals such as emollients, preservatives, and fragrances.Personal care & cosmeticsPubChem
CEDs000611Anti Perspirants Or Body Deoderants?Antiperspirants and body deodorants commonly contain synthetic chemicals such as aluminum compounds, parabens, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000614Essential Oils Or Perfumes?Essential oils and perfumes are complex mixtures of volatile compounds derived from natural or synthetic sources, commonly used for their aromatic properties.Personal care & cosmeticsPubChem
CEDs000615Eye Makeup Products?Eye makeup products, including mascaras, eyeliners, and eyeshadows, often contain a variety of synthetic chemicals such as pigments, preservatives, and film-forming agents.Personal care & cosmeticsPubChem
CEDs000616Face Mask Cosmetics?Face mask cosmetics often contain a variety of synthetic chemicals, including preservatives, emulsifiers, and fragrances, which can contribute to chemical contamination.Personal care & cosmeticsPubChem
CEDs000617Lip Care Products?Lip care products, including lipsticks, balms, and glosses, often contain a variety of synthetic chemicals such as parabens, phthalates, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000618Lip Makeup Products?Lip makeup products, such as lipsticks, lip glosses, and lip liners, often contain a variety of synthetic chemicals, including pigments, preservatives, and emollients.Personal care & cosmeticsPubChem
CEDs000632Apparel?Apparel production often involves the use of various synthetic chemicals, including dyes, finishing agents, and preservatives.Textiles, leather & furnishingsPubChem
CEDs000634Buckles?Buckles, commonly used as fasteners in clothing, accessories, and furniture, can be a source of synthetic chemical contamination due to the materials and coatings employed in their production.Textiles, leather & furnishingsPubChem
CEDs000642Footwear?Footwear production often involves the use of various synthetic chemicals, such as adhesives, dyes, and treatments, which can contribute to environmental contamination.Textiles, leather & furnishingsPubChem
CEDs000658Touch Fasteners?Touch fasteners, commonly known as hook-and-loop fasteners, are composed of synthetic materials such as nylon or polyester.Textiles, leather & furnishingsPubChem
CEDs000678Nitrogenous Fertilisers?Nitrogenous fertilizers are synthetic chemical compounds primarily used to enhance plant growth by supplying essential nitrogen, a crucial nutrient for photosynthesis and protein synthesis.Agriculture & land managementPubChem
CEDs000679Phosphatic Fertilisers?Phosphatic fertilizers are synthetic chemical products primarily composed of phosphorus, which is essential for plant growth.Agriculture & land managementPubChem
CEDs000685Ceramics?Ceramics can be a source of synthetic chemical contamination through various additives and processing agents used in their production.Building & ConstructionPubChem
CEDs000688Glass Coatings?Glass coatings are synthetic chemical formulations applied to glass surfaces to enhance properties such as durability, UV resistance, and aesthetic appeal.Building & ConstructionPubChem
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
CEDs000738Cooling Circuit Water?Cooling circuit water is utilized in various industrial processes to absorb and dissipate heat generated during operations.Industrial manufacturing & chemical processingPubChem
CEDs000740Paper?Paper production involves the processing of wood fibers and the use of various chemicals, which can lead to synthetic chemical contamination.Paper, pulp & fiber productsPubChem
CEDs000743Sludge Treatment?Sludge treatment involves the processing of waste materials generated from wastewater treatment plants, which often contain a variety of organic and inorganic substances.Wastewater, sanitation & biosolidsPubChem
CEDs000744Water, Wastewater, & Sewage Treatment?Water, wastewater, and sewage treatment processes are critical for managing and mitigating pollutants in water systems.Wastewater, sanitation & biosolidsPubChem
CEDs01371Infant FormulaeFood, food processing & cookwarePMC12430217
CEDs01947Olfactory EpitheliumIndustrial manufacturing & chemical processingPMC10525688
CEDs02261Sea WaterAquatic systems & sedimentsPMC11166142
Pathways
62 pathwaysPathway Source: PathBank
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
RNA N(6)-adenosine-methyltransferase METTL16 structureClick to view 3D structureRNA N(6)-adenosine-methyltransferase METTL16Q86W50HumansKnownNot Available
Click to view 3D structureN(6)-adenine-specific methyltransferase METTL4Q8N3J2HumansKnownNot Available
Adenosylhomocysteinase structureClick to view 3D structureAdenosylhomocysteinaseP23526HumansKnownNot Available
Splicing factor 1 structureClick to view 3D structureSplicing factor 1Q15637HumansKnownNot Available
Adenosine deaminase structureClick to view 3D structureAdenosine deaminaseP00813HumansKnownNot Available
Adenosine kinase structureClick to view 3D structureAdenosine kinaseP55263HumansKnownNot Available
NAD-capped RNA hydrolase NUDT12 structureClick to view 3D structureNAD-capped RNA hydrolase NUDT12Q9BQG2HumansKnownNot Available
N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 structureClick to view 3D structureN(6)-adenosine-methyltransferase non-catalytic subunit METTL14Q9HCE5HumansKnownNot Available
Insulin-like growth factor 2 mRNA-binding protein 3 structureClick to view 3D structureInsulin-like growth factor 2 mRNA-binding protein 3O00425HumansKnownNot Available
Adenosine receptor A2b structureClick to view 3D structureAdenosine receptor A2bP29275HumansKnownNot Available
N(6)-adenosine-methyltransferase catalytic subunit METTL3 structureClick to view 3D structureN(6)-adenosine-methyltransferase catalytic subunit METTL3Q86U44HumansKnownNot Available
Caspase-3 structureClick to view 3D structureCaspase-3P42574HumansKnownNot Available
Click to view 3D structureAdenosine receptor A2aP30543Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.811
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
174
E-value
0.0778492
Click to view 3D structureAdenosine receptor A1P25099Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.804
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
221
E-value
0.0778492
Adenosine receptor A3 structureClick to view 3D structureAdenosine receptor A3P0DMS8HumansPredicted (SEA)
Prediction Confidence Score
0.801
Applicability Domain
1.0
Statistical Significance
6.00e-05
Supporting Reference Compounds
391
E-value
0.467095
Click to view 3D structureAdenosine receptor A3P28647Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.801
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
71
E-value
0.0778492
Heat shock protein HSP 90-alpha structureClick to view 3D structureHeat shock protein HSP 90-alphaP07900HumansPredicted (SEA)
Prediction Confidence Score
0.782
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
109
E-value
0.0778492
Endoplasmin structureClick to view 3D structureEndoplasminP14625HumansPredicted (SEA)
Prediction Confidence Score
0.782
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
31
E-value
0.0778492
Adenosine receptor A2a structureClick to view 3D structureAdenosine receptor A2aP29274HumansPredicted (SEA)
Prediction Confidence Score
0.747
Applicability Domain
1.0
Statistical Significance
5.00e-05
Supporting Reference Compounds
303
E-value
0.389246
Adenosine receptor A1 structureClick to view 3D structureAdenosine receptor A1P30542HumansPredicted (SEA)
Prediction Confidence Score
0.737
Applicability Domain
1.0
Statistical Significance
1.00e-04
Supporting Reference Compounds
302
E-value
0.778492
Click to view 3D structureAdenosine receptor A1P47745Cavia porcellusPredicted (SEA)
Prediction Confidence Score
0.696
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
38
E-value
0.0778492
Click to view 3D structureS-methyl-5'-thioadenosine phosphorylaseQ9CQ65Mus musculusPredicted (SEA)
Prediction Confidence Score
0.686
Applicability Domain
0.686
Statistical Significance
4.00e-05
Supporting Reference Compounds
1
E-value
0.311397
Purine nucleoside phosphorylase structureClick to view 3D structurePurine nucleoside phosphorylaseP00491HumansKnownNot Available
Adenosine receptor A2b structureClick to view 3D structureAdenosine receptor A2bP29275HumansPredicted (SEA)
Prediction Confidence Score
0.672
Applicability Domain
1.0
Statistical Significance
2.00e-04
Supporting Reference Compounds
187
E-value
1.55698
Adenosine kinase structureClick to view 3D structureAdenosine kinaseP55263HumansPredicted (SEA)
Prediction Confidence Score
0.655
Applicability Domain
0.814
Statistical Significance
2.00e-05
Supporting Reference Compounds
22
E-value
0.155698
P2Y purinoceptor 1 structureClick to view 3D structureP2Y purinoceptor 1P47900HumansPredicted (SEA)
Prediction Confidence Score
0.654
Applicability Domain
0.686
Statistical Significance
1.40e-04
Supporting Reference Compounds
42
E-value
1.08989
Click to view 3D structureP2Y purinoceptor 2P41231HumansPredicted (SEA)
Prediction Confidence Score
0.649
Applicability Domain
0.686
Statistical Significance
3.90e-04
Supporting Reference Compounds
44
E-value
3.03612
Adenosine kinase structureClick to view 3D structureAdenosine kinaseP9WID5Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)Predicted (SEA)
Prediction Confidence Score
0.648
Applicability Domain
0.814
Statistical Significance
1.00e-05
Supporting Reference Compounds
4
E-value
0.0778492
High affinity choline transporter 1 structureClick to view 3D structureHigh affinity choline transporter 1Q9GZV3HumansPredicted (SEA)
Prediction Confidence Score
0.643
Applicability Domain
1.0
Statistical Significance
2.00e-05
Supporting Reference Compounds
75
E-value
0.155698
ADP-ribose glycohydrolase MACROD1 structureClick to view 3D structureADP-ribose glycohydrolase MACROD1Q9BQ69HumansPredicted (SEA)
Prediction Confidence Score
0.643
Applicability Domain
0.643
Statistical Significance
9.00e-05
Supporting Reference Compounds
1
E-value
0.700643
ADP-ribose glycohydrolase MACROD2 structureClick to view 3D structureADP-ribose glycohydrolase MACROD2A1Z1Q3HumansPredicted (SEA)
Prediction Confidence Score
0.643
Applicability Domain
0.643
Statistical Significance
9.00e-05
Supporting Reference Compounds
1
E-value
0.700643
Click to view 3D structureNAD kinaseQ5HH78Staphylococcus aureus (strain COL)Predicted (SEA)
Prediction Confidence Score
0.639
Applicability Domain
0.639
Statistical Significance
1.00e-05
Supporting Reference Compounds
1
E-value
0.0778492
NAD kinase 1 structureClick to view 3D structureNAD kinase 1Q8Y8D7Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e)Predicted (SEA)
Prediction Confidence Score
0.639
Applicability Domain
0.639
Statistical Significance
1.00e-05
Supporting Reference Compounds
1
E-value
0.0778492
Click to view 3D structureP2Y purinoceptor 1P49652Meleagris gallopavoPredicted (SEA)
Prediction Confidence Score
0.637
Applicability Domain
0.686
Statistical Significance
1.40e-04
Supporting Reference Compounds
19
E-value
1.08989
Heat shock cognate 71 kDa protein structureClick to view 3D structureHeat shock cognate 71 kDa proteinP19120Bos taurusPredicted (SEA)
Prediction Confidence Score
0.636
Applicability Domain
0.636
Statistical Significance
1.20e-04
Supporting Reference Compounds
1
E-value
0.934191
Sensor protein kinase WalK structureClick to view 3D structureSensor protein kinase WalKQ9RDT3Staphylococcus aureusPredicted (SEA)
Prediction Confidence Score
0.636
Applicability Domain
0.636
Statistical Significance
1.20e-04
Supporting Reference Compounds
1
E-value
0.934191
P2X purinoceptor 1 structureClick to view 3D structureP2X purinoceptor 1P51575HumansPredicted (SEA)
Prediction Confidence Score
0.632
Applicability Domain
0.66
Statistical Significance
1.20e-04
Supporting Reference Compounds
35
E-value
0.934191
Histone-lysine N-methyltransferase, H3 lysine-79 specific structureClick to view 3D structureHistone-lysine N-methyltransferase, H3 lysine-79 specificQ8TEK3HumansPredicted (SEA)
Prediction Confidence Score
0.628
Applicability Domain
0.745
Statistical Significance
8.00e-05
Supporting Reference Compounds
18
E-value
0.622794
Adenosine receptor A2a structureClick to view 3D structureAdenosine receptor A2aP29274HumansKnownNot Available
Adenosine receptor A3 structureClick to view 3D structureAdenosine receptor A3P0DMS8HumansKnownNot Available
Adenosine receptor A1 structureClick to view 3D structureAdenosine receptor A1P30542HumansKnownNot Available
Adenosine receptor A2b structureClick to view 3D structureAdenosine receptor A2bP29275HumansKnownNot Available
Glyceraldehyde-3-phosphate dehydrogenase structureClick to view 3D structureGlyceraldehyde-3-phosphate dehydrogenaseP04406HumansKnownNot Available
Adenosine deaminase structureClick to view 3D structureAdenosine deaminaseP00813HumansKnownNot Available
Epidermal growth factor receptor structureClick to view 3D structureEpidermal growth factor receptorP00533HumansKnownNot Available
Inosine-5'-monophosphate dehydrogenase 1 structureClick to view 3D structureInosine-5'-monophosphate dehydrogenase 1P20839HumansKnownNot Available
Inosine-5'-monophosphate dehydrogenase 2 structureClick to view 3D structureInosine-5'-monophosphate dehydrogenase 2P12268HumansKnownNot Available
Protein kinase C beta type structureClick to view 3D structureProtein kinase C beta typeP05771HumansKnownNot Available
Concentrations
Not Available
External Links
DrugBank IDDB00640
HMDB IDHMDB0000050
FooDB IDFDB003554
Phenol Explorer IDNot Available
KNApSAcK IDC00007444
BiGG ID34273
BioCyc IDADENOSINE
METLIN ID86
PDB IDNot Available
Wikipedia LinkAdenosine
Chemspider ID54923
ChEBI ID16335
PubChem Compound ID60961
Kegg Compound IDC00212
YMDB IDYMDB00058
ECMDB IDECMDB00050
References
Synthesis Reference

Giorgio Stramentinoli, Federico Gennari, “Process for preparing adenosine derivatives of anti-inflammatory and analgesic activity.” U.S. Patent US4373097, issued October, 1965.

MSDSLink
General References
  1. Nakayama Y, Kinoshita A, Tomita M: Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition. Theor Biol Med Model. 2005 May 9;2:18. [PubMed: 15882454]
  2. Eells JT, Spector R: Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma. Neurochem Res. 1983 Nov;8(11):1451-7. [PubMed: 6656991]
  3. Skalhegg BS, Funderud A, Henanger HH, Hafte TT, Larsen AC, Kvissel AK, Eikvar S, Orstavik S: Protein kinase A (PKA)--a potential target for therapeutic intervention of dysfunctional immune cells. Curr Drug Targets. 2005 Sep;6(6):655-64. [PubMed: 16178799]
  4. Lee SH, Jung BH, Kim SY, Chung BC: A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection. Rapid Commun Mass Spectrom. 2004;18(9):973-7. [PubMed: 15116424]
  5. Maytin M, Colucci WS: Cardioprotection: a new paradigm in the management of acute heart failure syndromes. Am J Cardiol. 2005 Sep 19;96(6A):26G-31G. [PubMed: 16181820]
  6. Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, Kapiloff MS, Scott JD: The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature. 2005 Sep 22;437(7058):574-8. [PubMed: 16177794]
  7. Gheorghiade M, Teerlink JR, Mebazaa A: Pharmacology of new agents for acute heart failure syndromes. Am J Cardiol. 2005 Sep 19;96(6A):68G-73G. [PubMed: 16181825]
  8. Jansen RW, Kruijt JK, van Berkel TJ, Meijer DK: Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes. Hepatology. 1993 Jul;18(1):146-52. [PubMed: 7686877]
  9. Ballantyne PJ: Social context and outcomes for the ageing breast cancer patient: considerations for clinical practitioners. J Clin Nurs. 2004 Mar;13(3a):11-21. [PubMed: 15028034]
  10. Yamamoto T, Moriwaki Y, Takahashi S, Fujita T, Tsutsumi Z, Yamakita J, Shimizu K, Shiota M, Ohta S, Higashino K: Determination of adenosine and deoxyadenosine in urine by high-performance liquid chromatography with column switching. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):55-61. [PubMed: 9869364]
  11. Koeris M, Funke L, Shrestha J, Rich A, Maas S: Modulation of ADAR1 editing activity by Z-RNA in vitro. Nucleic Acids Res. 2005 Sep 21;33(16):5362-70. Print 2005. [PubMed: 16177183]
  12. Vidotto C, Fousert D, Akkermann M, Griesmacher A, Muller MM: Purine and pyrimidine metabolites in children's urine. Clin Chim Acta. 2003 Sep;335(1-2):27-32. [PubMed: 12927681]
  13. Dunne VG, Bhattachayya S, Besser M, Rae C, Griffin JL: Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition 1H NMR study. NMR Biomed. 2005 Feb;18(1):24-33. [PubMed: 15455468]